Shareholders of the healthcare market research company IMS Health, Norwalk, Conn., have approved an acquisition deal that calls for the company to be purchased by investment funds managed by TPG Capital and CPP Investment Board, according to a news release.
TPG Capital, CPP Investment to acquire IMS Health
The proposed deal, announced in November, calls for the funds to pay $5.2 billion in cash and debt assumption to acquire IMS. The deal's closing is subject to additional conditions established in the acquisition agreement and customary regulatory review. The deal is expected to close in late March 2010.
What do you think? Post a comment on this article and share your opinion with other readers. Submit your comments to Modern Healthcare Online at [email protected]. Please be sure to include your hometown and state, along with your organization and title.
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.